Susquehanna International Group’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.1K Sell
13,156
-17,355
-57% -$84.4K ﹤0.01% 12545
2025
Q4
$142K Buy
30,511
+12,032
+65% +$54.5K ﹤0.01% 11213
2025
Q3
$88K Buy
+18,479
New +$63.5K ﹤0.01% 11644
2025
Q1
Sell
-14,835
Closed -$46.3K 13392
2024
Q4
$46.3K Buy
+14,835
New +$50.5K ﹤0.01% 11709

Other funds holding SOPH

Susquehanna International Group's SOPH Position: Q1 2026 in Review

Susquehanna International Group reduced its SOPHiA GENETICS (SOPH) stake by 57% in Q1 2026, selling an estimated $84.4K and leaving 13,156 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12545.

Susquehanna International Group first reported a position in SOPH in Q4 2024 and has held it in 4 quarters since. The position peaked at $142K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Susquehanna International Group held 13,156 shares of SOPHiA GENETICS worth $65.1K as of Q1 2026.
  • Susquehanna International Group sold 17,355 SOPHiA GENETICS shares in Q1 2026, an estimated $84.4K.
  • SOPHiA GENETICS made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12545 holding.
  • Susquehanna International Group first reported a position in SOPHiA GENETICS in Q4 2024 and has held it in 4 quarters since.
  • Susquehanna International Group's SOPHiA GENETICS position peaked at $142K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.